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Abstract 
As a novel temperature-sensitive liposome, dioleoylphosphatidylethanolamine vesicles bearing poly( N-isopropylacrylamide), which 
shows a lower critical solution temperature (LCST) near 32”C, were designed. Poly(N-isopropylacrylamide) having long alkyl chains 
which are anchors to the lipid membranes was prepared by radical copolymerization of N-isopropylacrylamide and octadecyl acrylate 
using azobisisobutyronitrile as the initiator. The copolymer obtained revealed the LCST at about 30°C in an aqueous solution. 
Dioleoylphosphatidylethanolamine vesicles coated with the copolymer was prepared and release property of the copolymer-coated 
vesicles was investigated. While release of calcein encapsulated in the copolymer-coated vesicles was limited below 3O”C, the release was 
drastically enhanced between 30 nad 35°C. Complete release from the vesicles was achieved within several seconds at 40°C. This 
temperature-controlled release property of the vesicles can be attributable to stabilization and destabilization of the vesicle membranes 
induced by the copolymer fixed on the vesicles below and above the LCST, respectively. Moreover, the fluorometric measurement using 
dioleoyl-N-(7-nitrobnz-2-oxa-I,3-diazol-4-yl)phosphatidylethanolamine suggested that the extensive release of calcein observed above 
the LCST is resulted from the bilayer to H,, phase transition of the vesicle membranes. Since LCST of the copolymer is controllable, 
these vesicles might have potential usefulness as a drug delivery system with high temperature-sensitivity. 
Keywords: Liposome; Temperature-sensitivity; Dioleoylphosphatidylethanolamine; Poly( N-isopropylacrylamide); Lower critical solution temperature; 
Lamellar-hexagonal transition; Drug delivery system 
1. Introduction 
With respect to site specific delivery of drugs, a number 
of attempts have been made to develop liposomes which 
can regulate release of drugs responding to various exter- 
nal stimuli such as pH [l-3], light [4-61, and temperature 
[7]. In particular, temperature-sensitive liposomes have 
been shown to enhance the efficacy of drugs [g-11] and 
may be the best for medical application among these 
stimuli-responsive liposomes. So far, temperature-sensitive 
liposomes have been prepared using phospholipids with 
the liquid-crystalline phase transition temperature a few 
degrees above physiological [7]. However, temperature- 
sensitive liposomes of this type have some disadvantages. 
For example, temperature-sensitivity of these liposomes 
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with diameter less than 200 nm is relatively low [ 12- 141. 
Also, available lipids for these liposomes are quite limited. 
Recently, as another approach to prepare temperature- 
sensitive liposomes, modification of liposomes with a 
thermo-sensitive polymer such as poly( N-isopro- 
pylacrylamide) has been proposed [ 15 181. Poly( N-isopro- 
pylacrylamide) shows a lower critical solution temperature 
(LCST) at 30-3.5X [19,20]. The polymer is hydrophilic 
and soluble in water below the LCST, but becomes hy- 
drophobic and forms insoluble aggregates above that tem- 
perature due to hydrophobic interactions and formation of 
intermolecular hydrogen bondings [ 15,191. 
Two strategies for preparation of temperature-sensitive 
liposomes may be possible using the thermo-sensitive 
polymer. One is to use the polymer to destabilize liposo- 
ma1 membranes above the LCST of the polymer. However, 
in a previous study, we showed that release of encapsu- 
lated materials from phosphatidylcholine liposomes can 
128 H. HaFashi et al. /Biochimica et Biophwica Acta 1280 (IYY6/ 127-134 
not be controlled completely [17] because interaction of 
the polymer with the lipid membranes is not strong enough 
to destroy the phosphatidylcholine membrane [ 15,17,2 11. 
The other is to use the polymer to stabilize the liposomal 
membranes. It is well known that phosphatidylethanol- 
amine (PE) with unsaturated acyl chains does not form 
vesicles by itself under neutral conditions, but the vesicles 
can be prepared by adding another component which 
stabilizes PE membranes [22] such as fatty acids [23,24] 
and cholesterol derivatives [25,26]. If the thermo-sensitive 
polymer is used as such a stabilizer, it is expected that the 
polymer highly hydrated below the LCST stabilizes PE 
vesicle, but stabilizing ability of the polymer diminishes 
above the LCST, resulting in degradation of the vesicles. 
In this study, dioleoylphosphatidylethanolamine vesi- 
cles coated with poly(N-isopropylacrylamide) having long 
alkyl chains as anchors to the lipid membrane, namely a 
copolymer of N-isopropylacrylamide and octadecyl acry- 
late, were prepared and temperature-controlled release 
property of the copolymer-modified vesicles was studied. 
2. Materials and methods 
2.1. Materials 
L-a-Dioleoylphosphatidylethanolamine (DOPE), egg 
yolk phosphatidylcholine (EYPC) and calcein were pur- 
chased from Sigma (St. Louis, MO, USA). Dioleoyl-N-(7- 
nitrobenz-2-oxa- 1,3-diazol-4-yl)phosphatidylethanolamine 
(NBD-PE) was supplied by Avanti Polar Lipids (Bi- 
rmingham, AL, USA). N-Isopropylacrylamide (NIPAM), 
octadecyl acrylate (ODA) and azobisisobutyronitrile 
(AIBN) were obtained from Tokyo Kasei (Tokyo, Japan). 
Tris(hydroxymethyl)aminomethane (Tris), N,N-dimethyl- 
formamide (DMF), tetrahydrofuran (THF) and ethylene- 
diaminetetraacetic acid (EDTA) were supplied by Kishida 
Chemical (Osaka, Japan). NIPAM was purified by recrys- 
tallization from cyclohexane-n-hexane (1: 1) before use. 
2.2. Synthesis of copoly(NIPAM-ODA) 
A copolymer of NIPAM and ODA shown in Fig. 1 was 
prepared via the method previously reported [17]. In brief, 
I I 
NH (-3W+37 
I 
CH -CHa 
I 
dH, 
Fig. 1. Structure of copolymer of N-isopropylacrylamide and octadecyl 
acrylate. 
NIPAM (9.8 mmol), ODA (0.2 mmol) and AIBN (3.0. 
lo-’ mmol) were dissolved in THF (10 ml) and then the 
solution was heated at 60°C for 4 h in N, atmosphere. The 
copolymer was recovered by precipitation with dieth- 
ylether. The copolymer was dissolved in THF and repre- 
cipitated with diethylether. The dried copolymer was dis- 
solved in water. The solution was filtered. The copolymer 
was isolated by lyophilization of the solution. 
2.3. Preparation qf DOPE vesicles coated with 
copoly(NIPAM-ODA) 
DOPE vesicles were prepared as follows: a dry thin 
membrane of 10 mg of DOPE was dispersed in 1 ml of 
aqueous 20 mM calcein solution of pH 9.0. The solution 
was sonicated for 15 min by using a ultrasonic disruptor 
(Tomy Seiko, UD-201). Varying amounts of aqueous solu- 
tion of the copolymer (IO mg/ml, pH 9.0) containing 20 
mM calcein were added to the liposome suspension and 
incubated at 5.O”C for 4 h with stirring. Free calcein and 
the free copolymer were removed by gel permeation chro- 
matography on a Sephacryl S-400 column at 10°C using 
10 mM Tris-HCl-buffered solution containing 40 mM 
NaCl and 0.1 mM EDTA at pH 9.0. 
2.4. Estimation of amount of copoly(NIPAM-ODAi bound 
to vesicles 
Amount of the copolymer bound to the vesicles was 
determined by high performance liquid chromatography 
analysis on Asahipak GF-310HQ using mixture of THF 
and water (2: 1, v/v) as an effluent. The copolymer-mod- 
ified vesicles were dissolved in the THF/water (2: 1, v/v) 
mixture by adding THF into aqueous dispersion of the 
vesicles, whose DOPE concentration was determined by 
the method of Bartlett [27] (typically ca. 4. 10m4 M). The 
solution of the copolymer-modified vesicles in THF/water 
mixture (20 ml) was injected into the column and the 
effluent was monitored by absorbance at 210 nm using a 
UV detector (Jasco, UV-970). The flow rate was 0.6 
ml/min. The void volume of the column was 4.0 ml. The 
elution volumes of the copolymer and DOPE were 5.0 ml 
and 9.7 ml, respectively. From the absorbance of the 
copolymer separated, the amount of the copolymer bound 
on the vesicle was determined. 
2.5. Calcein release from cesicles 
The release measurements were performed according to 
the method previously reported [17,28]. The vesicles con- 
taining 20 mM calcein in the inside was dispersed in 10 
mM Tris-HCl-buffered solution containing 40 mM NaCl 
and 0.1 mM EDTA of a given pH at various temperatures 
and the fluorescence intensity was monitored. The excita- 
tion and monitoring wavelengths were 493 and 5 15 nm, 
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respectively. The percent release of calcein from the vesi- 
cles was defined as 
F’- f7’ 
%release = ~ x 100 Ff. - F’ 
where F’ and F’ mean the initial and intermediate fluores- 
cence intensities of the vesicle suspension, respectively. F’ 
is the fluorescence intensity after the addition of Triton 
X- 100 (final concentration 0.15%). Because release of 
calcein from the copolymer-modified vesicles was very 
fast at temperatures above 35°C under neutral and weak 
acidic conditions, it is impossible to determine the F’ 
value directly. Under these conditions, the F’ value was 
obtained in the following manner. Since the release of 
calcein was quite slow at pH 9.0, fluorescence intensity of 
calcein entrapped in the vesicles could be determined 
accurately by eliminating F’ from F’. Therefore, in the 
measurement above 35°C under neutral and weak acidic 
conditions the F’ value was obtained by eliminating fluo- 
rescence of calcein entrapped in the vesicles, namely the 
value of F’ - F’ measured at pH 9.0 at a given tempera- 
ture, from the F’ value with correction for pH-dependent 
change of the fluorescence intensity although the change 
of fluorescent intensity was not significant under the ex- 
perimental conditions. 
2.6. Fluorescence measurement using NBD-PE 
Fluorescence measurement using NBD-PE was per- 
formed by the method of Hong et al. [29]. NBD-PE-labeled 
vesicles were prepared according to the above procedure 
using mixture of the lipids and NBD-PE (0.3 mol%). An 
aqueous solution of the copolymer (10 mg copolymer/ml, 
pH 9.0, 0.5 ml) was added to the labeled vesicles dispersed 
in 10 mM Tris-HCl-buffered solution containing 40 mM 
NaCl and 0.1 mM EDTA (10 mg lipid/ml, pH 9.0, 1 ml) 
and incubated at 5.O”C for 4 h with stirring. 
The vesicle suspension diluted to a given concentration 
was put in a quartz cuvette at a given temperature and then 
small volumes of HCl solution was added to change the 
pH of the solution from 9.0 to 7.3. Fluorescence intensity 
of the vesicle was monitored continuously during the 
above procedure by using a fluorescence spectrophotom- 
eter (Hitachi, F-3010). The excitation and the emission 
wavelengths were 475 and 530 nm, respectively. 
2.7. Other methods 
Phospholipid concentration was measured by the method 
of Bartlett [27]. Molecular weight of the copolymer was 
estimated by gel permeation chromatography analysis on 
Shodex KD-803 column (Showa Denko Co.) using DMF. 
The size of the vesicles was determined by quasielastic 
light scattering using a laser particle analyzing system 
(Otsuka Electronics, LPA 3100s). Nuclear magnetic reso- 
nance (NMR) spectra were taken with a JEOL JNM-GX- 
270 MHz instrument. Differential scanning calorimetry 
was performed with a Perkin Elmer DSC7 microcalorime- 
ter. The samples were analyzed at a heating rate of l.O”C 
/min in the temperature range of 20-35°C. 
3. Results and discussion 
3. I. Characterization of copolymer 
In order to obtain poly(NIPAM) with anchoring groups 
to the lipid membrane, we chose the copolymer of NIPAM 
and ODA because many studies indicate that hydrophilic 
polymers can be fixed on lipid membranes by conjugation 
of hydrophobic molecules to the polymers [ 17,30-331. 
Ringsdorf and his collaborators have already shown that 
hydrophobically-modified poly(NIPAM)s bind onto liposo- 
ma1 membranes and that the polymers bound on the liposo- 
ma1 membranes undergo a phase transition at the tempera- 
ture corresponding to the LCST of the polymers [2 1,321. 
The chemical composition of the copolymer prepared 
here was determined by ’ H-NMR spectra as shown in Fig. 
1. The weight average molecular weight (Mw), the number 
average molecular weight (Mn), and the heterogeneity 
index, Mw/Mn, were determined to be 9500, 5300, and 
1.8, respectively, using GPC analysis. 
The LCST of poly(NIPAM) can be determined by 
microcalorimetric methods [19,20]. Fig. 2 represents DSC 
curves of the copolymer in an aqueous solution and in the 
presence of a phospholipid. The copolymer exhibits a 
broad endotherm centered at about 30°C. This LCST value 
is somewhat lower than poly(NIPAM) itself. Since LCST 
of poly(NIPAM) as well as that of other thermo-sensitive 
polymers has already been shown to decrease when hy- 
drophobic residues are incorporated into the polymer [34- 
371, it is likely that hydrophobic octadecyl groups on the 
copolymer make the LCST of the copolymer lower than 
t 0” 
4 
20 22 24 26 26 30 32 34 36 
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Fig. 2. Microcalorimetric endotherms for aqueous copolymer samples in 
the absence (A) and in the presence (B) of EYPC vesicles. (A) 
Copoly(NIPAM-ODA) solution (5.0 wt%); (B) copoly(NIPAM-ODA) 
(2.5 wt7c) solution containing EYPC vesicle (2.5 wt%). The samples 
were heated at l”C/min. ilH for curves A and B are 4.1 and 3.8 Cal/g 
of the copolymer, respectively. 
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the LCST of poly(NIPAM) itself. On the other hand, the 
LCST value of the copolymer elevated slightly in the 
presence of EYPC liposome. Since the copolymer pos- 
sesses hydrophobic moieties, it might form a polymeric 
micelle in an aqueous solution [34,38], whereas in the 
presence of the lipid membrane the polymeric micelle 
should be disrupted as is observed in the presence of a 
surfactant by Winnik et al. 1381. Such a change of state of 
the copolymer may affect the aggregate formation of NI- 
PAM units of the copolymer, resulting in the slight differ- 
ence of LCST. 
Calorimetric enthalpy of endotherm (AH) associated 
with the LCST of the copolymer was ca. 4 Cal/g of the 
copolymer. This value is approximately consistent with the 
result reported by Schild and Tirrell [20]. 
3.2. Characterization of copolymer-mod$ied DOPE cesi- 
cles 
Although PE with unsaturated acyl chains does not 
form vesicles by itself under the physiological condition, it 
is known that unilamellar PE vesicles can be produced at 
high pH, where the ammonium group is deprotonated and 
the head group is negatively charged [22,39,40]. Allen et 
al. reported that stable PE liposomes form above pH 8 and 
lamellar-hexagonal (Hi,) transition of PE does not occur 
above pH 8.4 [41]. Since it is known that DOPE vesicle 
can be obtained above pH 8.6 [42], in this study prepara- 
tion of DOPE vesicle and incubation of the vesicle with 
the copolymer were carried out at pH 9.0. 
We prepared DOPE vesicles bearing varying amounts 
of copoly(NIPAM-ODA) by controlling the amount of the 
copolymer added to DOPE vesicles. The amount of the 
copolymer added to DOPE vesicles were 0, 0.05, 0.1, 0.25 
and 0.5 mg/mg lipid. The diameter of the copolymer- 
modified vesicles obtained by adding 0, 0.1 and 0.5 mg of 
the copolymer per 1 mg of the lipid was estimated to be 
105, 94 and 97 nm, respectively, by quasielastic light 
scattering. It is apparent that the diameter of the vesicles 
was hardly affected by coating with the copolymer, al- 
though the copolymer-modified vesicles showed a some- 
what smaller diameter compared with the bare DOPE 
vesicle. Since the copolymer bound to the vesicles is 
highly hydrated below its LCST, the polymer may sup- 
press contact between the vesicles and hence aggregation 
and/or fusion of the vesicles. The amounts of the copoly- 
mer bound to the vesicles obtained by adding 0.1, 0.25 and 
0.5 mg of the copolymer were estimated to be 0.042, 0.113 
and 0.113 mg/mg DOPE, respectively, by high perfor- 
mance liquid chromatography. This result indicates that the 
amount of the copolymer adsorbed on the vesicle reaches 
to a constant value in the presence of excess of the 
copolymer. This value corresponds to ca. 1.5 NIPAM units 
per one DOPE molecule in the outer leaflet of the vesicle 
membrane, assuming that the vesicle consists of single 
bilayer membrane and the copolymer adsorbed only on the 
outer leaflet of the membrane. 
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Fig. 3. Typical profiles of calcein release from the copolymer-modified 
vesicle suspended in 10 mM Tris-HCI-buffered solution containing 40 
mM NaCl and 0.1 mM EDTA at pH 7.4 at various temperatures: +, 
20°C; W , 25°C; v , 30°C; A, 35°C; 0, 40°C. The concentration of lipid 
was 1 IO-’ mol/l. The vesicle was prepared by incubation in the 
aqueous solution containing 5 mg of the copolymer (see Section 2 in the 
text). 
3.3. Release behavior of copolymer-modified DOPE uesi- 
cles 
Temperature-dependence of release of calcein from the 
copolymer-modified DOPE vesicles was investigated. The 
copolymer-modified vesicles and the unmodified vesicle 
containing calcein released essentially the same amount of 
calcein after the addition of Triton X- 100. Moreover, when 
the vesicles which did not contain calcein in the inner 
aqueous phase were incubated in an aqueous calcein solu- 
tion for 1 h at 5°C and subsequently separated from free 
calcein by gel permeation chromatography, the release of 
calcein from the resultant vesicles of either modified and 
unmodified types was not observed by adding Triton X- 
100. These facts indicate that calcein is entrapped in the 
inner aqueous space of the vesicles and the modification of 
the vesicles with the copolymer does not affect the encap- 
sulation of calcein in the vesicles. 
Fig. 3 shows profiles of release of calcein entrapped in 
the copolymer-modified vesicle. While release of calcein is 
limited below 30°C rapid and extensive release was in- 
duced above 35°C. The release was completed within 
several seconds at 40°C. Fig. 4 represents percent release 
of calcein from the copolymer-modified and -unmodified 
DOPE vesicles after 30 s as a function of temperature. In 
the case of unmodified vesicle, a monotonous increase in 
percent release was observed. As is seen in Fig. 4, the data 
of the unmodified vesicle have large deviations, because 
the unmodified vesicle was highly unstable at pH 7.4. 
Nevertheless, complete disintegration of the vesicle did not 
occur immediately after addition into the buffer of pH 7.4. 
Since destabilization of PE vesicles requires contact be- 
tween the bilayers [25,43&l, prompt rupture of the vesicle 
might not be induced even above the lamellar-hexagonal II 
(H,,) phase transition temperature (T,) of DOPE mem- 
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brane. In fact, it was reported that an increase in tempera- 
ture to above the 7’” does not induce the phase transition 
of PE membrane at physiological pH when the vesicles are 
unaggregated [41]. 
By contrast, release of calcein from the copolymer- 
modified vesicle changes drastically between 30 and 35°C. 
This temperature region agrees well with LCST of the 
copolymer. By comparison of curves in Fig. 4, it is 
apparent that coating of the copolymer on the vesicle 
surface results in reduction of the release below 30°C and 
enhancement of the release above 35°C. 
In order to clarify the effect of the copolymer on release 
property of DOPE vesicle, release of calcein from the 
vesicles coated with various amounts of the copolymer 
was investigated. Fig. 5 depicts percent release of calcein 
from DOPE vesicles prepared by the incubation with 
various amounts of the copolymer. The number of abscissa 
indicates the weight ratio of the copolymer supplied to 
DOPE vesicle during the incubation. As mentioned above, 
the copolymer-modified vesicles prepared by the incuba- 
tion with the ratio copolymer/DOPE of 0.25 and 0.5 
revealed the same composition. The extent of release from 
the vesicles increases with increasing amounts of the 
copolymer at 40°C. By contrast, below 30°C the release 
was suppressed with increasing amounts of the copolymer 
adsorbed on the vesicle. The effect of the copolymer at 
35°C is complicated compared with those at 30 and 40°C. 
When the weight ratio of copolymer to lipid is below 0.1, 
percent release decreases with increasing amounts of the 
copolymer bound on the vesicle. However, the vesicles 
bearing larger amounts of the copolymer reveal significant 
release. 
It is known that PE liposomes, under nonaggregating 
conditions, exist in the bilayer state at temperatures well 
100 
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Fig. 4. Percent release of calcein from the copolymer-modified DOPE 
vesicle (0) and the unmodified DOPE vesicle (0) as a function of 
temperature in 10 m M  Tris-HCl-buffered solution containing 40 m M  
NaCl and 0.1 m M  EDTA at pH 7.4. Percent release after 30 s  is shown in 
the figure. The bars represent the standard deviation (n = 3). The copoly- 
mer-modified vesicle was prepared by incubation in the aqueous solution 
containing 5 mg of the copolymer (see Section 2 in the text). 
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Fig. 5. Effect of the amount of copolymer fixed on the vesicle on the 
release property of the vesicle in IO m M  Tris-HCI-buffered solution 
containing 40 m M  NaCl and 0.1 m M  EDTA at pH 7.4 at various 
temperatures: n , 25°C; T, 30°C; A, 35’C; 0, 40°C. Percent release 
after 30 s  is shown in the figure. The number of abscissa indicates the 
weight ratio of the copolymer supplied to DOPE vesicle during the 
incubation (see Section 2 in the text). 
above the Hi, transition temperature and do not release 
their contents [41]. Therefore, PE liposomes can be ob- 
tained under the physiological condition by preventing the 
interbilayer contact, which induces H,, phase formation 
[22,25]. A number of PE bilayer stabilizers have been 
reported. For example, highly hydrophilic proteins such as 
immunoglobulin G  [45] and glycophorin A [46] can stabi- 
lize DOPE vesicles. Similarly, the copolymer adsorbed on 
the vesicle reduces the bilayer contact below the LCST 
because the copolymer becomes highly hydrated and ex- 
tended under the condition. With increasing amounts of the 
copolymer adsorbed on the vesicle, the bilayer contact 
should be inhibited and hence, the vesicle is stabilized 
more strongly, resulting in decrease in the extent of re- 
lease. On the other hand, the copolymer shrinks and forms 
aggregate above the LCST. This shrinkage induces genera- 
tion of the bare lipid membrane surface, which triggers 
destabilization of the vesicle. However, only the exposure 
of bare surface is not sufficient to bring about destabiliza- 
tion of the vesicle, as is indicated in Fig. 5, in which 
remarkable enhancement of release of calcein from the 
vesicles bearing small amount of the copolymer is not 
observed at 35°C. The copolymer becoming hydrophobic 
above the LCST should interact with DOPE membrane 
and also facilitate aggregation and contact of the vesicles. 
In fact, increase in turbidity of the copolymer-coated vesi- 
cles of DOPE as well as other lipids such as dipalmitoyl- 
phosphatidylcholine was observed (results not shown). 
Such interactions should promote transition from lamellar 
phase to H,, phase and then significant and rapid release 
from the vesicles takes place [25,43,44]. In addition, it is 
known that polar solutes such as poly(ethylene glycol) 
increase the bilayer-to-H,, transition temperature of PE 
[47], whereas non-polar solutes such as n-alkanes promote 
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Fig. 6. Percent release of calcein from the copolymer-modified (closed 
symbols) and the unmodified (open symbols) DOPE vesicles as a func- 
tion of pH in 10 m M  Tris-HCI-buffered solution containing 40 m M  NaCl 
and 0.1 m M  EDTA at 25°C (0,O) and 35°C ( 0, W  1. Percent release 
after 60 s  is shown in the figure. The copolymer-modified vesicle was 
prepared by incubation in the aqueous solution containing 5 mg of the 
copolymer (see Section 2 in the text). 
the formation of H,, phase [48,49]. Therefore, it seems 
possible that the interaction of the hydrated or dehydrated 
copolymer with the membrane affects the phase transition 
temperature differently. 
Since the bilayer-to-H,, transition of PE is affected by 
pH [4 11, release property of the copolymer-modified DOPE 
vesicles is expected to reveal pH-dependence in the pH 
region where the ionization state of amino group of the 
lipid changes. Fig. 6 shows percent release of calcein from 
the modified and unmodified DOPE vesicles after 60 s at 
varying pH values. The release from the unmodified vesi- 
cle increases as pH decreases at 35°C as well as at 25°C 
probably because protonation of amino group of the lipid 
enhances the bilayer-to-H,, transition. A similar increase 
of the percent release with decreasing pH is observed for 
the copolymer-modified vesicle at 35°C suggesting the 
common mechanism of destabilization with the unmodi- 
fied vesicle. By contrast, enhancement of release from the 
copolymer-modified vesicle was hardly seen at 25°C even 
when pH was decreased to 6.1. This result indicates that 
the membrane of the vesicle takes the lamellar phase and 
the bilayer-to-H,, transition of the membrane is strongly 
suppressed at least above pH 6.1. 
3.4. Fluorornetric detection of the phase transition oj 
DOPE vesicle in the presence of the copolymer 
If the extensive calcein release from the copolymer- 
modified vesicles observed above 35°C is resulted from 
the bilayer-to-H,, phase transition of the vesicle mem- 
branes and subsequent rapture of the vesicles, the phase 
transition is expected to occur at the temperature. The 
bilayer-to-H,, phase transition of lipid membranes can be 
detected by various techniques such as ‘i P-NMR, DSC, 
freeze-fracture electron microscopy and fluorometry [49]. 
Among them the fluorometric technique using NBD-PE is 
well established and is suitable to determine the bilayer-to- 
H,, phase transition in dilute membrane suspensions 
[29,50]. When NBD-PE is incorporated in a lipid mem- 
brane which undergo the bilayer-to-H,, phase transition, 
NBD-PE fluorescence increases during the bilayer-to-H ,, 
phase transition. 
We prepared the DOPE vesicles containing NBD-PE 
and fluorescence intensity of NBD-PE was investigated at 
varying temperatures (Fig. 7). When pH of the vesicle 
suspension was changed from 9.0 to 7.3 at a given temper- 
ature by adding an aqueous HCl solution, the fluorescence 
intensity increased and reached to the maximum value 
after about 30 s (data not shown), as reported by Hong et 
al. [29]. The maximum value F,,,, is considered to repre- 
sent the fluorescence of the equilibrium state under the 
new condition [29]. Fig. 7A shows F,,, of NBD-PE 
incorporated in the DOPE vesicle membrane in the pres- 
ence or absence of the copolymer as a function of tempera- 
ture at pH 7.3. In the absence of the copolymer F,,,, 
decreases continuously. Although hydrated DOPE has the 
bilayer-to-H,, phase transition temperature of 5-10°C [49], 
the transition can not be detected possibly because the 
transition temperature is shifted and lowered a few degrees 
in the presence of NBD-PE [29]. By contrast, in the 
presence of the copolymer an increase of F,,,, is appar- 
ently seen between 30 and 35°C suggesting occurrence of 
the phase transition. In order to confirm the appearance of 
the transition, we performed the fluorescence measurement 
at pH 9.0, where DOPE takes the lamellar phase. As is 
seen in Fig. 7B, a continuous decrease of F,,, with 
temperature is observed in the presence of the copolymer 
as well as in the absence of the copolymer and hence, 
dehydration of the copolymer does not affect F,,,. 
Moreover, NBD-PE-labeled vesicle of EYPC which 
does not undergo the bilayer-to-H,, phase transition was 
also prepared and F,,, of NBD-PE in the EYPC vesicle 
membrane in the presence and in the absence of the 
copolymer was investigated (Fig. 7C). It has already been 
shown that the copolymer reveals a similar affinity for 
EYPC vesicle as well as for DOPE vesicle [ 171. A continu- 
ous decrease of F,,,,, with temperature is observed in the 
absence of the copolymer and also in the presence of the 
copolymer as is observed in the case of DOPE vesicles at 
pH 9.0. These results indicate that (1) at pH 9.0 DOPE 
vesicle membrane takes lamellar phase in the presence of 
the copolymer as well as in the absence of the copolymer 
and (2) at pH 7.3 in the presence of the copolymer the 
DOPE vesicle membrane exhibits the lamellar-to-hexago- 
nal (Hi,) transition at the LCST of the copolymer. 
3.5. Concluding remarks 
Since liposomes injected into the blood circulate in the 
body, a rapid release property is important for effective 
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Fig. 7. Fluorescence intensity of NBD-PE-labeled DOPE (A, B) and 
EYPC (C) vesicles as a function of temperature in 10 m M  Tris-HCI- 
buffered solution containing 40 m M  NaCl and 0.1 m M  EDTA at pH 7.3 
(A,C) and at pH 9.0 (B) in the absence (w) and in the presence (0) of 
the copolymer. The concentration of the lipids was 6.3. IO-” M. 
site-specific delivery of drugs by temperature-sensitive 
liposomes. Therefore, it is noteworthy that the copolymer- 
coated DOPE vesicles reveal a fast and extensive release 
of their content responding to environmental temperature 
change. Because the LCST of this type of polymers can be 
controlled by copolymerization with monomers with vary- 
ing hydrophobicity or hydrophilicity [35-371, it is possible 
to prepare vesicles which reveal critical temperature for 
the destabilization a few degrees above the physiological 
temperature. At present, this new technology is indeed 
immature. For example, toxicity of these vesicles in the 
body is unknown. However, by using thermo-sensitive 
polymers with low toxicity, their application for tempera- 
ture-sensitive drug delivery system with high sensitivity 
might be possible. 
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